Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)
China flag China · Delayed Price · Currency is CNY
5.98
-0.48 (-7.43%)
Nov 17, 2026, 3:00 PM CST

Jiangsu Nanfang Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
559.66599.72602.01599.66544.78523.74
Other Revenue
0.790.790.60.430.593.7
560.45600.51602.62600.1545.37527.44
Revenue Growth
-5.78%-0.35%0.42%10.04%3.40%-50.82%
Cost of Revenue
554.31586.22631.53566.33477.73432.92
Gross Profit
6.1414.29-28.9133.7667.6394.52
Selling, General & Admin
47.550.8894.7959.9556.1770.97
Research & Development
26.1628.6128.7228.1827.7330.62
Other Operating Expenses
7.565.875.166.525.664.35
Operating Expenses
88.6195.04112.14124.5493.99110.53
Operating Income
-82.47-80.75-141.05-90.77-26.36-16.01
Interest Expense
-3.27-21.73-26.43-23.19-20.18-11.8
Interest & Investment Income
9.539.588.699.159.388.8
Earnings From Equity Investments
0.05-----
Currency Exchange Gain (Loss)
0.260.26-1.040.585.85-3.76
Other Non Operating Income (Expenses)
-21.01-2.5-3.85-9.33-1.53-6.67
EBT Excluding Unusual Items
-96.92-95.14-163.68-113.56-32.85-29.43
Gain (Loss) on Sale of Investments
-0.04-0.04-1.31.23-
Gain (Loss) on Sale of Assets
--0.26-4.29-0.030.05
Asset Writedown
0.49--38.4-34.17--2.48
Other Unusual Items
0.82.030.962.22.311.17
Pretax Income
-95.67-93.14-200.86-148.52-29.34-30.69
Income Tax Expense
8.297.97-10.36-1.23-14.41-7.65
Earnings From Continuing Operations
-103.96-101.12-190.5-147.29-14.94-23.04
Minority Interest in Earnings
-1.83-0.59-0.17-0.130.290.28
Net Income
-105.79-101.71-190.67-147.42-14.65-22.76
Net Income to Common
-105.79-101.71-190.67-147.42-14.65-22.76
Net Income Growth
------
Shares Outstanding (Basic)
291291289289293285
Shares Outstanding (Diluted)
291291289289293285
Shares Change
0.52%0.59%-0.06%-1.34%2.97%-0.60%
EPS (Basic)
-0.36-0.35-0.66-0.51-0.05-0.08
EPS (Diluted)
-0.36-0.35-0.66-0.51-0.05-0.08
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
17.8117.9250.89-50.65-114.88-296.01
Free Cash Flow Per Share
0.060.060.18-0.17-0.39-1.04
Gross Margin
1.09%2.38%-4.80%5.63%12.40%17.92%
Operating Margin
-14.71%-13.45%-23.41%-15.13%-4.83%-3.03%
Profit Margin
-18.88%-16.94%-31.64%-24.57%-2.69%-4.32%
Free Cash Flow Margin
3.18%2.98%8.44%-8.44%-21.07%-56.12%
EBITDA
--30.71-91.01-36.514.8612.87
EBITDA Margin
--5.11%-15.10%-6.08%2.73%2.44%
D&A For EBITDA
-50.0450.0454.2741.2228.88
EBIT
-82.47-80.75-141.05-90.77-26.36-16.01
EBIT Margin
-14.71%-13.45%-23.41%-15.13%-4.83%-3.03%
Revenue as Reported
153.21600.51602.62600.1545.37527.44
Advertising Expenses
-0.81.971.090.670.48